Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001309088 | SCV001498570 | likely benign | X-linked Emery-Dreifuss muscular dystrophy | 2023-12-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002350560 | SCV002649658 | uncertain significance | Cardiovascular phenotype | 2021-10-21 | criteria provided, single submitter | clinical testing | The p.M191T variant (also known as c.572T>C), located in coding exon 6 of the EMD gene, results from a T to C substitution at nucleotide position 572. The methionine at codon 191 is replaced by threonine, an amino acid with similar properties. Based on data from gnomAD, the C allele has an overall frequency of 0.002% (3/183126) total alleles studied, with 2 hemizygotes observed. The highest observed frequency was 0.004% (3/818780) of European (non-Finnish alleles). This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001835515 | SCV002084699 | uncertain significance | Emery-Dreifuss muscular dystrophy | 2021-08-05 | no assertion criteria provided | clinical testing |